1. Analysis of human cerebrospinal fluid monoamines and their cofactors by HPLC
- Author
-
Simon Heales, Rafael Artuch, Cristina Sierra, Marta Batllori, Manju A. Kurian, Marta Molero-Luis, Aida Ormazabal, Mercedes Casado, Simon Pope, and Angels García-Cazorla
- Subjects
Quality Control ,0301 basic medicine ,Chromatography ,Biogenic Monoamines ,High-performance liquid chromatography ,Vitamin B 6 ,General Biochemistry, Genetics and Molecular Biology ,Pterins ,03 medical and health sciences ,chemistry.chemical_compound ,030104 developmental biology ,0302 clinical medicine ,Cerebrospinal fluid ,chemistry ,Calibration ,Humans ,Sample preparation ,Centrifugation ,Trichloroacetic acid ,Pyridoxal phosphate ,Derivatization ,Chromatography, High Pressure Liquid ,030217 neurology & neurosurgery - Abstract
The presence of monoamines and their cofactors (the pterins and vitamin B6 (pyridoxal phosphate (PLP))) in human cerebrospinal fluid (CSF) can be used as indicators of the biosynthesis and turnover of dopamine and serotonin in the brain. In addition, abnormalities in the CSF levels of these molecules are associated with various neurological diseases, including genetic diseases leading to dopamine and serotonin deficiency. Here, we provide a set of quantitative high-performance liquid-chromatography (HPLC) approaches to determine CSF levels of monoamines and their cofactors. This protocol describes step-by-step procedures for CSF sample preparation for the analysis of different molecules, HPLC calibration and analysis, and data quantification and interpretation. Unlike plasma/tissue/blood samples, CSF requires minimal sample preparation: in this protocol, only the analysis of PLP requires mixing with trichloroacetic acid to release the protein-bound vitamin, centrifugation, and mixing of the supernatant with phosphate buffer and sodium cyanide for derivatization in alkaline conditions. Monoamines are analyzed by HPLC with coulometric electrochemical detection (ED), pterins are analyzed by HPLC with coupled coulometric electrochemical and fluorescence detection, and PLP is analyzed by HPLC with fluorescence detection. The quantification of all compounds is achieved by external calibration procedures, and internal quality control and standards are analyzed in each run. We anticipate that investigation of dopamine and serotonin disturbances will be facilitated by measurements of these compounds in human CSF and other biological samples. The estimated time for the different procedures primarily depends on the electrochemical detector stabilization. Overnight stabilization of this detector is advised, and, after that step, preanalytical equilibration rarely exceeds 3 h.
- Published
- 2017
- Full Text
- View/download PDF